Published Apr 30, 2026, 6:54 PM ET · Updated 6 months ago · 1 source
Novo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO
bloomberg
·
Original Report
INFERY
Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company that counts Novo Nordisk Foundation as one of its biggest investors, raised $301.5 million in an upsized US initial public offering that priced at the top of a marketed range.